
Interactive Updates on Selected Topics in Gynecology Oncology
Preliminary Program
Co-Chairs



Advances & Updates Webinar:
Are Surgeons Collecting Enough Tumor Tissue in Laparoscopic Biopsies for HRD Testing?
Thursday, June 16, 2022
7:00 AM ET (New York)
Moderator: Tom Herzog, MD
Sponsored in part by Myraid
Advances & Updates Webinar:
Ocular Toxicities & Management of Other Adverse Events with ADC's
Recorded live on Tuesday, May 17, 2022
Moderator: Floor Backes, MD
Presenter: Gottfried E. Konecny, MD
Presenter: Mark Slabaugh, MD
Sponsored in part by Immunogen and Seagean
Advances & Updates Webinar:
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
Recorded live on Tuesday, May 10, 2022
Presenter: Vicky Makkers, MD
Advances & Updates Webinar:
SORAYA Trial Data with Dr. Ursula A. Matulonis
Recorded live on Wednesday, May 4, 2022
Presenter: Ursula Matulonis, MD
Moderator: Robert Coleman, MD
Sponsored in part by Immunogen.
Visit Advances & Updates Education portal page for more.
IJGC Journal Club, in collaboration with IGCS and ESGO
IJGC is proud to host a monthly Zoom Journal Club, which can be followed on Twitter at #IJGCclub.
Every month, members of our Editorial Board join the authors of IJGC lead articles on Zoom to discuss and debate their research and other relevant topics in an informal, collegial setting. Chats are open to the public, enabling authors to discuss their work with a global audience and increase understanding and awareness of current studies in gynecological oncology.
Lead Article: Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty by Katherine Hicks-Courant
When? Tuesday, June 14 at 11 am CDT | 6 pm CET
Registration is not required. To join the June IJGC chat, use this Zoom Link to join at the scheduled time.
View recordings of journal club discussions below.
IJGC Podcasts features short interview segments with leading experts discussing the latest research in their respective areas.
Select episodes are available in other languages including Arabic, Spanish, French, Italian, and Russian.
The Surgical Film Festival dedicated to Upper Abdominal Surgery for Ovarian Cancer was held live, March 11, 2022.
The recording is available to IGCS members in the Education Portal.
IGCS is providing a free online surgical film festival narrated by expert surgeons in the field of gynecologic oncology. Attendees can participate in live discussion while viewing the surgical films and hear from the global experts.
Email education@igcs.org for questions and comments.
Pulmonary trans-thoracic resection in a patient with HGS ovarian carcinoma and a residual nodule after NACT
René Pareja, MD
Colombia
Splenectomy and mesenteric stripping
Christina Fotopoulou, MD
UK
IGCS surgical film festivals are organized by Vance Broach and Reitan Ribeiro, Surgical Education Leads of the IGCS Education Committee.
The IGCS Education360 Podcast features interview segments with international leading experts discussing the latest advances and updates in gynecologic cancer therapeutics, surgery, and applications to clinical practice. The contributors provide commentary on the latest data from clinical trials and give their opinion on what the data means regarding potential treatment options and identify knowledge gaps requiring further research.
Antibody-Drug Conjugates (ADCs) are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Unlike chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells. In this episode you will learn the following:
Featured on this episode:
Dr. Brad Monk
Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network) and the University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital Phoenix, USA and Medical Director US Oncology Research Network - Gynecologic Program
Dr. Kathleen Moore
Virginia Kerley Cade Endowed Chair in Cancer Developmental Therapeutics Associate Director Clinical Research, Director, Oklahoma TSET Phase I Program, Stephenson Cancer Center and Associate Professor, Section of Gynecologic Oncology At the University of Oklahoma Health Sciences Center
Angela Ralte, MBBS, MD, FRCPATH
Consultant Pathologist, Cellular Pathology
South of Tyne and Wear Pathology | Queen Elizabeth Hospital
Gateshead, UK
Dr. Sakinah A Thiryayi
Gynepathologist & Cytopathologist, Pathology and Laboratory Medicine
Sinai Health | Bridgepoint Active Healthcare
Toronto, Canada
How Cemiplimab is EMPOWERING change in the management of recurrent cervix cancer
Funded with a grant from Regeneron.
Mirvetuximab Soravtansine, an Antibody-Drug Conjugate Targeting the Folate Receptor for Women with Ovarian Cancer
New Perspectives in Ovarian Cancer: Current Paradigm and Long-term Benefits of PARPi Therapy
Solutions to Address Missed Opportunities for Genetic Testing Globally
The Evolution of NGS for Gynecologic Malignancies: Delivering for Future for More Precise Treatment
The evolving treatment of landscape of gynecological tumors
Antibody Drug Conjugates in Treating Recurrent Ovarian Cancer: The Next Generation - A Focus on NaPi2b
Platinum-Resistant Ovarian Cancer: Treatment Landscape and Future Opportunities